The treatment of respiratory diseases
CA 2405705 C · Owner: Morton, David A. V. · Inventors: Bannister, Robin Mark; Richards, Andrew John Mcglashan; Gilbert, Julian Clive
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A pharmaceutical composition for pulmonary delivery comprises glycopyrrolate in a controlled release formulation, wherein on administration, the , glycopyrrolate exerts its pharmacological effect over a period greater than 12 hours.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 9, 2001 and granted June 7, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 9, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 9, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.